Invasion by esophageal cancer cells: Functional contribution of the urokinase plasminogen activation system, and inhibition by antisense oligonucleotides to urokinase or urokinase receptor. Clinical & Experimental Metastasis 17(1): 77-85, 1999
Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor. Journal of Biological Chemistry 269(41): 25668-25676, 1994
The Urokinase/Urokinase Receptor System in Mast Cells: Effects of its Functional Interaction with fMLF Receptors. Translational Medicine @ Unisa 15: 34-41, 2016
Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic a2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor. The Journal of Biological Chemistry 269: 668-76, 1994
Urokinase receptor expression on monocytes and plasma urokinase content are decreased in coronary artery disease. European Heart Journal 18(ABSTR Suppl. ): 631, 1997
Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits urokinase/urokinase-receptor expression and MMP-9 secretion by peripheral blood monocytes--a possible protective mechanism against atherothrombosis. Thrombosis and Haemostasis 84(4): 680-688, 2000
Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. Proceedings of the National Academy of Sciences of the United States of America 82(15): 4939-4943, 1985
Inhibition of the tumor-associated urokinase-type plasminogen activation system: effects of high-level synthesis of soluble urokinase receptor in ovarian and breast cancer cells in vitro and in vivo. Recent Results in Cancer Research. Fortschritte der Krebsforschung. Progres Dans les Recherches sur le Cancer 162: 43-63, 2003
High-affinity urokinase-derived cyclic peptides inhibiting urokinase/urokinase receptor-interaction: Effects on tumor growth and spread. FEBS Letters 528(1-3): 212-216, 25 September, 2002
A hybrid protein of urokinase growth-factor domain and plasminogen-activator inhibitor type 2 inhibits urokinase activity and binds to the urokinase receptor. European Journal of Biochemistry 207(1): 177-183, 1992
Urokinase-related proteins in human urine. Isolation and characterization of single-chain urokinase (pro-urokinase) and urokinase-inhibitor complex. Journal of Biological Chemistry 261(3): 1267-1273, 1986
Effect of purified, soluble urokinase receptor on the plasminogen-pro-urokinase activation system. Febs Letters. 393(1): 31-36, 1996